迷幻药用于治疗强迫症:有效性和建议的机制
1MRC Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
The international journal of neuropsychopharmacology
|November 29, 2024
概括
迷幻药物,特别是 псилоцибин,在治疗强迫症 (OCD) 方面表现有前途. 研究表明,这些化合物可以减少强迫症症状,尽管机制需要进一步调查.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 迷幻药正在探索各种心理健康状况.
- псилоцибин是一种具有潜在治疗应用的迷幻化合物.
- 强迫症 (OCD) 是一种令人虚弱的精神健康状况.
研究的目的:
- 审查支持迷幻药物用于强迫症治疗的证据.
- 检查强迫症中迷幻药的作用机制的建议.
- 讨论当前证据的局限性和未来的研究方向.
主要方法:
- 对现有文献进行系统审查.
- 对案例研究和临床试验的分析.
- 评估临床前 (动物模型) 数据.
主要成果:
- 自20世纪60年代以来的案例研究报告了迷幻药使用对强迫症行为的改善.
- 2006年的一项开放标签试验表明,psilocybin显著降低了强迫症症状.
- 在强迫症的动物模型中,psilocybin的使用减少了强迫行为.
结论:
- 证据支持幻化药的潜力,比如西宾,用于治疗强迫症.
- 机制可能涉及急性药理效应,神经可塑性变化或心理影响.
- 需要进一步的研究和正在进行的试验来澄清疗效和机制.
相关概念视频
Obsessive-Compulsive Disorder
54
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
54
CNS Stimulants: Psychedelic Agents
127
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
127
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Psychosis and Antipsychotic Drugs: Overview
178
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
178


